Zhendong Pharmaceutical has received a letter of inquiry about the annual report for three consecutive years. The sale of its subsidiary has taken out Fangyuan Capital. Zhendong Pharmaceutical, Fangyuan Capital, Shenzhen Stock Exchange_Sina Technology_Sina.com

Key Data Concepts:   

? These are the company names, stock quotes, topics, and entities related to this data.

000989 300158 300170 300376 China Shipbuilding Industry Group Power Citic Securities East Group Co Fujian Funeng Hand Enterprise Solutions Harbin Pharmaceutical Group Jiuzhitang LBX Pharmacy Chain Joint Stock Company Shanxi Zhendong Pharmaceutical Xinjiang Sayram Modern Agriculture Arts, Culture, Entertainment, Media Arts, Entertainment Regulations Accounting, Audit Shareholder Management Strategy, Marketing Annual, Special Corporate Meeting Annual Report Research, Development Health, Beauty Product Pharmaceutical Financial, Business Service Market, Exchange University Nature Diseases, Conditions Hospital Medicine People Pet Product, Service Cooperative Economy, Business, Finance Environment Health

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Home » News » Zhendong Pharmaceutical has received a letter of inquiry about the annual report for three consecutive years. The sale of its subsidiary has taken out Fangyuan Capital. Zhendong Pharmaceutical, Fangyuan Capital, Shenzhen Stock Exchange_Sina Technology_Sina.com